GROWTH Network

The GROWTH consortium, funded by the European Commission (2019-2023), is made up to train a new generation of researchers working on new pathological insights, biomarker diagnostics and personalized nutritional interventions for intestinal failure in neonates and preterm infants.


People

Academic and industry partners, covering various disciplines ranging from fundamental research to clinical paediatrics and analytical chemistry to organoid and gut-on-chip applications, have teamed up in the European Union.


Research Programme

GROWTH aims to set-up a new European platform that trains young scientists in the industry-led exploration of innovative routes to fully exploit the potential of early life nutrition to prevent inflammatory disease. GROWTH coordinates 8 individual research projects.


Contact

If you have any questions you can fill in the form or mail us directly: info@growth-horizon2020.eu.




NEWS & EVENTS

Expert Lecture Series on "Omics Technologies / Bio-informatics Analyses" organized in the GROWTH network

With Covid-19 greatly affecting the fellows' training programme, the GROWTH consortium organizes an Expert Lectures Series on a relevant topic chosen by the students.

As of December 2020 an Expert Lecture Series with "Omics technologies / Bio-informatics analyses) as main training theme is being organized with specialist lecture every other Friday. Till now the following lectures have taken place or are planned till May 2021.


Presenters:

Dr. Andrew Li Yim (DSCN Research): RNA sequencing - Transcriptomics.

Dr. Evgeni Levin (HorAIzon): Machine learning approaches.

Dr. Hilde Herrema (Amsterdam UMC): Bacteriophages.

Drs. Deepak Balamurali (Maastricht University): Next-Gen Sequencing: Design & Overview.

Dr. Theo Hakvoort (Amsterdam UMC): Fungal ITS sequencing.

Dr. Marcus de Goffau (University of Cambridge): Reagent contamination in sequencing studies.

Dr. Andrew Li Yim (DSCN Research): Single cell RNA sequencing.

Prof. Dr. Dr. Ahmed Hegazy (Charite University Berlin): Cytokines in the pathogenesis of Inflammatory bowel diseases.